Meeting
2016 ASCO Annual Meeting
Phase I trial of paclitaxel, bevacizumab, and temsirolimus in advanced solid malignancies.
Authors
Shannon Neville Westin
The University of Texas MD Anderson Cancer Center, Houston, TX
Shannon Neville Westin , Erin Stashi , Navdeep Pal , Diana L Urbauer , Filip Janku , Sarina Anne Piha-Paul , Aung Naing , Apostolia Maria Tsimberidou , Siqing Fu , David S. Hong , Vivek Subbiah , Daniel D. Karp , Robert L. Coleman , Funda Meric-Bernstam , Razelle Kurzrock
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Developmental Therapeutics—Clinical Pharmacology and Experimental Therapeutics
Track
Developmental Therapeutics and Translational Research
Sub Track
Small Molecules
Clinical Trial Registration Number
NCT01187199
Citation
J Clin Oncol 34, 2016 (suppl; abstr 2573)
DOI
10.1200/JCO.2016.34.15_suppl.2573
Abstract #
2573
Poster Bd #
273
Abstract Disclosures
Similar Posters
Poster
2013 ASCO Annual Meeting
Phase I trial of sorafenib, bevacizumab, and temsirolimus in advanced solid tumors.
First Author: Shannon Neville Westin
Poster
2019 ASCO Annual Meeting
A phase I study of a novel MDM2 antagonist APG-115 in patients with advanced solid tumors.
First Author: Drew W. Rasco
Poster
2018 Gastrointestinal Cancers Symposium
A phase I study of veliparib (Vel) in combination with oxaliplatin (Ox) and capecitabine (Cap) in advanced solid tumors.
First Author: Anita Ahmed Turk
Poster
2024 ASCO Gastrointestinal Cancers Symposium
Phase 1/2 evaluation of revumenib in patients with advanced colorectal cancer and other solid tumors.
First Author: Aparna Raj Parikh